Android app on Google Play

Sagent Pharmaceuticals (SGNT) IPO Opens Higher

April 20, 2011 11:06 AM EDT Send to a Friend
Sagent Pharmaceuticals (Nasdaq: SGNT) IPO is open for trading. Shares are trading at $18.11 after pricing an up-sized offering of 5,750,000 shares at $16, the high end of the expected $14-$16 range.

Morgan Stanley, BofA Merrill Lynch, and Jefferies are acting as the joint bookrunners for the offering.

Sagent Pharmaceuticals, founded in 2006, is a specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectable products.

You May Also Be Interested In

Related Categories

Hot IPOs, IPOs, Trader Talk

Related Entities

Morgan Stanley, Jefferies & Co, Merrill Lynch, Bank of America

Add Your Comment